In CAD patients with DM, patients with eGFR ≤ 60 mL/min/1.73 m2 and elevated ET‐1 levels had a 2.297‐fold (95% CI 1.822–2.895) increased risk of MACE. This evidence concerns the gene EDN1 and diabetes mellitus.